Cas:1134529-25-1 2-(Aminomethyl)benzonitrile hydrochloride manufacturer & supplier

We serve Chemical Name:2-(Aminomethyl)benzonitrile hydrochloride CAS:1134529-25-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

2-(Aminomethyl)benzonitrile hydrochloride

Chemical Name:2-(Aminomethyl)benzonitrile hydrochloride
CAS.NO:1134529-25-1
Synonyms:Benzonitrile, 2-(aminomethyl)-, hydrochloride (1:1);2-(aminomethyl)benzonitrile,hydrochloride;2-(Aminomethyl)benzonitrile hydrochloride (1:1)
Molecular Formula:C8H9ClN2
Molecular Weight:168.624
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:49.81000
Exact Mass:168.045425
LogP:2.51928

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like Benzonitrile, 2-(aminomethyl)-, hydrochloride (1:1) chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-(Aminomethyl)benzonitrile hydrochloride (1:1) physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-(aminomethyl)benzonitrile,hydrochloride Use and application,Benzonitrile, 2-(aminomethyl)-, hydrochloride (1:1) technical grade,usp/ep/jp grade.


Related News: The CHMP concluded that the benefits of Zynteglo continue to outweigh its risks. As for all medicines, the EMA will monitor any new data on its safety and update advice for patients and healthcare professionals when necessary. dimethoxy-(2-methylbutan-2-yl)-[(2-methylpropan-2-yl)oxy]silane manufacturers Despite the $13 million first-quarter hit from the rate cut, iRhythm grew revenue year over year by 17% to $74.3 million in the quarter. iRhythm’s net losses for the quarter totaled $27.8 million, compared to a net loss of $9.1 million in the first quarter of 2020. Phosphenodithioic fluoride suppliers J.P. Morgan and William Blair analysts still backed iRhythm for the long-term despite its recent challenges. William Blair analysts wrote that the company is still a leader of a cardiac monitoring market that is under 20% penetrated and valued at approximately $2 billion. silyl vendor & factory.